Your browser doesn't support javascript.
loading
Population pharmacokinetic analysis of esomeprazole in Japanese subjects with various CYP2C19 phenotypes.
Nagase, Mario; Shimada, Hitoshi; Nii, Masahiro; Ueda, Shinya; Higashimori, Mitsuo; Ichikawa, Katsuomi; Zhang, Li; Zhou, Li; Chen, Yingxue; Zhou, Diansong; Dunyak, James; Al-Huniti, Nidal.
Afiliação
  • Nagase M; Quantitative Clinical Pharmacology, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Boston, MA, USA.
  • Shimada H; Clinical Pharmacology & Drug Safety and Metabolism, AstraZeneca KK, Osaka, Japan.
  • Nii M; Clinical Pharmacology & Drug Safety and Metabolism, AstraZeneca KK, Osaka, Japan.
  • Ueda S; Clinical Pharmacology & Drug Safety and Metabolism, AstraZeneca KK, Osaka, Japan.
  • Higashimori M; Clinical Pharmacology & Drug Safety and Metabolism, AstraZeneca KK, Osaka, Japan.
  • Ichikawa K; Clinical Pharmacology & Drug Safety and Metabolism, AstraZeneca KK, Osaka, Japan.
  • Zhang L; Quantitative Clinical Pharmacology, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Boston, MA, USA.
  • Zhou L; Quantitative Clinical Pharmacology, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Boston, MA, USA.
  • Chen Y; Quantitative Clinical Pharmacology, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Boston, MA, USA.
  • Zhou D; Quantitative Clinical Pharmacology, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Boston, MA, USA.
  • Dunyak J; Quantitative Clinical Pharmacology, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Boston, MA, USA.
  • Al-Huniti N; Quantitative Clinical Pharmacology, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Boston, MA, USA.
J Clin Pharm Ther ; 45(5): 1030-1038, 2020 Oct.
Article em En | MEDLINE | ID: mdl-32227647

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores da Bomba de Prótons / Esomeprazol / Citocromo P-450 CYP2C19 / Modelos Biológicos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Humans / Male País como assunto: Asia Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores da Bomba de Prótons / Esomeprazol / Citocromo P-450 CYP2C19 / Modelos Biológicos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Humans / Male País como assunto: Asia Idioma: En Ano de publicação: 2020 Tipo de documento: Article